Claim your FREE Special Rebel Research Report, Big Pharma Failure Creates Massive Investment Opportunity
There’s more to the Helus Pharma (NASDAQ: HELP) story than we have the room to discuss here. That’s why we’ve prepared an exclusive Special Rebel Research Report with even more details about this unique company and why it could be a big winner for investors. It’s called Big Pharma Failure Creates Massive Investment Opportunity — and you can get a FREE copy immediately when you accept a risk-free trial membership in the Rebel Investors Club. …
How the Rebel Investors Club Gives You a Profit Advantage
As a member of the Rebel Investors Club every month you’ll receive our exclusive newsletter revealing…
Overlooked and undervalued stock picks based on our in-depth research and analysis, so you have the opportunity to profit in any market
Critical forecasts and analysis of economic trends, geopolitical developments, financial trends, political doings, and more, so you know what’s coming and how to prepare for it
Exclusive analysis of key sectors, to give you insight into where the next great profit opportunities lie
For aggressive investors only: Carefully selected option opportunities for investors with greater risk tolerance who want to go for big gains
Plus, as a member, you’ll also receive:
Flash Alerts whenever you need to take immediate action to protect your money or to jump into a potential high profit opportunity. We’ll email you immediately when something develops that you need to know about right now.
Quarterly webinars to bring you up-to-date on our latest thinking and strategies. Plus, you’ll have the opportunity to hold our feet to the fire by asking your most pressing questions.
24/7 Access to our Members-Only Website: This is where you’ll find everything you need to make rapid progress toward your financial and investment goals, including back issues, Special Reports, White Papers, Model Portfolios and much, much more.
Accept a Risk-Free Trial Membership Today, Save 25% and Get Up to Five FREE Bonus Gifts Valued at $2,033.47
A two-year membership in Rebel Investors Club is just $560 — a 25% discount off the regular price.
Better yet, when you join today, you’ll also receive up to five FREE bonus gifts valued at up to $2,033.47:
- Free Gift #1: Big Pharma Failure Creates Massive Investment Opportunity — a $500 value
In this exclusive Special Rebel Research Report, you’ll get even more details about Helus Pharma (NASDAQ: HELP) to help you and your investing advisor to make a wise decision about whether it belongs in your portfolio.
- Free Gift #2: Rebel Investors Club Quick Start Guide — a $500 value
- Free Gift #3: The Business of Space: How One IPO Will Change Everything — a $500 value
- Free Gift #4: Trump and Beyond: Five Economic and Investment Forecasts for the Years Ahead — a $500 value
Plus, when you subscribe within 10 days, you’ll get an extra FREE gift:
- Free Gift #5: Our renowned book, Follow the Smart Money — a $33.47 value
Better yet, you take zero risk when you accept a trial membership in the Rebel Investors Club because…
You’re Fully Protected by Our IRONCLAD, 100% Money-Back Double Guarantee
First, you must be delighted with the investment opportunities we bring you and the money you make as a new member. If not, you may cancel within the first 30 days of membership, and we’ll rush you a full refund of every penny you paid, with no questions asked. No hard feelings either.
Second, in the unlikely event you do cancel, you may keep every issue and special report that you have received or downloaded for your trouble. You don’t have to return a thing.
Activate Your Risk-Free Membership Today
As you’ve seen, we created the Rebel Investors Club to share expert insights and opportunities that investors can use to grow their wealth in the uncertain times ahead.
Now it’s your turn to get these insights by joining the Rebel Investors Club.
To get started, simply pick up the phone and call Toll-Free 1 (888) 809-8058 (Monday–Friday, 8am–6pm ET, ) or visit BiotechInvestingToday.com.
However, whether you decide to join us or not, be sure to speak with your financial advisor about investing in Helus Pharma (Nasdaq: HELP).
Subscribe to the Rebel Investors Club, save up to $187, and receive up to Five FREE gifts valued at up to $2,033.47!
A risk-free two-year membership in the Rebel Investors Club is just $560 — a 25% discount off the regular $747 price. Plus, when you subscribe for two years today, you’ll receive up to Five FREE gifts valued at up to $2033.47:
Here's everything you need to know about Helus Pharma (NASDAQ: HELP) and why it could bring you big time profits, thanks to its drugs in development that are showing tremendous promise for the treatment of depression and anxiety. Use this Special Report to get started on your own research.
A Rebels Guide to getting the most out of your Rebel Investors Club subscription. Everything you need to hit the ground running from day one.
Musk's SpaceX IPO is expected to be the biggest ever. In this Special Rebel Research Report, we share our picks for the stocks most likely to benefit from this epic, market-changing IPO.
Donald Trump's America-First economic policies moved markets on a daily basis in the first year of his second term. In this Rebel Research Report we share our insights on the policies that will shape the rest of DJT's term, particularly in the wake of the mid-term elections.
Pete & Jon Najarian have been teaching independent traders how to "Follow the Smart Money" for decades. In this book — a must-read for traders — they share the tactics and strategies that made the Najarian Brothers two of the most successful traders of all time.
10 days
2-Year Membership selected — click above to continue
You’re Fully Protected by Our IRONCLAD, 100% Money-Back Double Guarantee
To make your decision completely risk-free, we’re offering you a 30-Day, 100% Money-Back Double Guarantee when you join the Rebel Investors Club — giving you plenty of time to explore all the insights, strategies, and opportunities this membership provides.
If for any reason you’re not absolutely delighted with the investment opportunities we bring you, simply cancel within the first 30 days and we’ll issue a full refund of every penny you paid — no questions asked and no hard feelings. To cancel, just call 1 (888) 809-8058, available Monday through Friday, 8AM to 6PM ET, and our team will take care of everything for you.
And here’s where it gets even better …
Even if you decide to cancel, you’ll keep every issue and all special Rebel Research Reports you’ve received or downloaded, including up to five FREE Special Reports valued at $2,033.47. You won’t need to return a thing. That’s what makes our Money-Back Double Guarantee — zero risk, zero hassle.
This guarantee is only possible because our team at Rebel Investors Club is completely confident you’ll see the real-world value of our research, recommendations, and expert insights — especially in today’s uncertain markets.
That’s also why we will never auto-renew or auto-bill your membership. You stay in complete control at all times.
In short, you have absolutely nothing to lose — and a great deal of insight, opportunity, and value to gain.
Disclaimers
MPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of Helus Pharma (NASDAQ: HELP). Rebel Investors Club is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to sell or a solicitation of an offer to purchase any securities. In an effort to enhance public awareness, Helus Pharma (NASDAQ: HELP) provided advertising agencies with a total budget of approximately $2,914,712 and is the sole source of funds to cover the costs associated with creating, printing and distribution of this advertisement. From that total budget, Moneta Advisory Partners, an affiliate of Rebel Investors Club was paid $500,000 as a research fee and for the production and placement of additional advertising media for this campaign. The advertising agencies will retain any excess sums after all expenses are paid. Rebel Investors Club may receive subscription revenue in the future from new subscribers as a result of this advertisement for its newsletter.
While this advertisement is being disseminated and for a period of not less than 90 days thereafter, Rebel Investors Club , the advertising agencies, and their respective officers, principals, or affiliates will not sell securities of Helus Pharma (NASDAQ: HELP). If successful, this advertisement will increase investor and market awareness of Helus Pharma (NASDAQ: HELP) and its securities, which may result in an increased number of shareholders owning and trading the securities, increased trading volume, and possibly an increase in share price, which may be temporary. This advertisement, the advertising agencies and Rebel Investors Club do not purport to provide a complete analysis of Helus Pharma (NASDAQ: HELP) or its financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors.
This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or, at a minimum, doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell, and only after reviewing the financial statements and other pertinent publicly-available information about Helus Pharma (NASDAQ: HELP). Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in Helus Pharma (NASDAQ: HELP) SEC filings. Investing in microcap securities such as Helus Pharma (NASDAQ: HELP) is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Rebel Investors Club cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions.
This advertisement contains forward-looking statements, including statements regarding expected continual growth of Helus Pharma (NASDAQ: HELP) and/or its industry. The advertising agencies and Rebel Investors Club note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect Helus Pharma (NASDAQ: HELP) actual results of operations. Factors that could cause actual results to vary include the size and growth of the market for Helus Pharma (NASDAQ: HELP) products and/or services, the company’s ability to fund its capital requirements in the near term and long term, federal and state regulatory issues, pricing pressures, etc.
Rebel Investors Club is the publisher’s trademark. All trademarks used in this advertisement other than Rebel Investors Club are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agencies and Rebel Investors Club are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks.